Evidence of Fraudulent Claims by Hologic/Gen-Probe in relation to Daniel Densham’s IP Portfolio. PacBio Deal rears its head.

Evidence of Fraudulent Claims by Hologic/Gen-Probe in relation to Daniel Densham’s IP Portfolio brings Pacbio Deal into focus.

The fraudulently claimed IP portfolio of Daniel Densham, Managing Director of Molecular Research Limited, appears have been Licensed to Pacific Biosciences Inc, within the questionable Pacific (gen probe)/Hologic deal. Read More

Pacific Bioscience’s VP of Intellectual Property, Robert Reamey, claims questionable public SEC document “confidential corporate document”, but may “answer questions” in “over the telephone” negotiations.

Pacific Biosciences VP, Intellectual Property, Robert.H.Reamey, on behalf of Pacific Biosciences, claims that public SEC document Exhibit 10.7, dated June 15th 2010, is “a confidential corporate document” and cannot be released.

Read More